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SUMMARY 
Dethiobiotin synthetase (DTBS) plays a crucial role in biotin biosynthesis in 
microorganisms, fungi, and plants. Due to its importance in bacterial pathogenesis, and 
the absence of a human homologue, DTBS is a promising target for the development of 
new antibacterials desperately needed to combat antibiotic resistance. Here we report 
the first X-ray structure of DTBS from Mycobacterium tuberculosis (MtDTBS) bound to a 
nucleotide triphosphate (CTP). The nucleoside base is stabilized in its pocket through 
hydrogen-bonding interactions with the protein backbone, rather than amino acid side 
chains. This resulted in the unexpected finding that MtDTBS could utilise ATP, CTP, 
GTP, ITP, TTP, or UTP with similar Km and kcat values, although the enzyme had the 
highest affinity for CTP in competitive binding and surface plasmon resonance assays. 
This is in contrast to other DTBS homologues that preferentially bind ATP primarily 
through hydrogen-bonds between the purine base and the carboxamide side chain of a 
key asparagine. Mutational analysis performed alongside in silico experiments revealed 
a gate-keeper role for Asn175 in Escherichia coli DTBS that excludes binding of other 
nucleotide triphosphates. Here we provide evidence to show that MtDTBS has a broad 
nucleotide specificity due to the absence of the gate-keeper residue.  
 
Keywords: enzyme, biotin biosynthesis; dethiobiotin synthetase; nucleotide 
triphosphate; crystal structure, Mycobacterium tuberculosis; Escherichia coli. 
 
	   3	  
 
1. INTRODUCTION 
De novo synthesis of biotin (aka vitamin H or B7) is an important metabolic activity for 
microorganisms, fungi and plants, which is not present in humans [1]. In bacteria, biotin 
serves as an essential cofactor for biotin-dependent enzymes, namely pyruvate 
carboxylase (PC) to replenish the Krebs cycle and acyl-CoA carboxylase (ACC) for 
membrane biogenesis and maintenance [2], [3], [4] and [5]. As the cell membrane 
provides a defensive barrier against environmental toxins, host immune factors and 
antibiotic agents [6] and [7], the metabolic pathways related to the synthesis of 
membrane lipids have been suggested as promising targets for the development of new 
antibiotics. Genetic studies have revealed important roles for biotin biosynthesis in 
Mycobacterium tuberculosis during growth, infection and the latency phase, thus 
establishing this pathway as a potential drug target for new anti-tuberculosis therapies 
[3], [8], [9], [10], [11] and [12]. In addition, biotin biosynthesis has been intensively 
studied in other bacteria and the enzymes involved in the pathway have been implicated 
in bacterial virulence during infection and intracellular replication [13].  
Dethiobiotin synthetase (DTBS, EC 6.3.3.3, encoded by bioD) controls the penultimate 
step of the biotin biosynthesis pathway, catalysing the closure of the ureido ring of 
dethiobiotin (DTB) from (7R, 8S)-7,8-diaminopelargonic acid (DAPA) using CO2 and a 
nucleotide triphosphate (NTP). The reaction mechanism has been proposed to involve 
three discrete steps, which are (1) the formation of N7-carbamate, (2) the formation of 
the carbamic-phosphoric acid anhydride, and (3) the closure of the ureido ring with the 
release of inorganic phosphate [14]. The amino acid residues required for binding the 
DAPA substrate and subsequent catalysis have been well characterized, with X-ray 
crystal structures available for the enzymes from Escherichia coli, M. tuberculosis, 
Helicobacter pylori, and Francisella tularensis [15], [16], [17] and [18]. However, the 
molecular details of NTP binding are less well defined, especially for M. tuberculosis 
DTBS (MtDTBS) where there is currently no crystal structure of the enzyme in complex 
with NTP. From the available structural data, the NTP binding site is divided into two 
discrete subsites; the phosphate-binding region (also known as the P-loop or Walker A 
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motif) and the nucleoside-binding pocket. In E. coli DTBS (EcDTBS), a conformational 
change involving the P-loop (Gly8-X-X-X-X-X-Gly14-Lys15-Th16) was observed 
following phosphate binding [16]. In contrast, a comparison of available MtDTBS 
structures revealed no homologous conformational change upon the binding of 
inorganic phosphate [15]. Comparison of the bacterial DTBS homologues revealed 
considerable structural differences in nucleoside recognition at the C-terminal region of 
DTBS [18]. For example, Asn175 in EcDTBS, found within the [NQ]-[KR]-x-[DE] GTP 
specificity motif, has been proposed  to play a key role in the adenosine specificity 
observed for E. coli, H. pylori and F. tularensis. However this amino acid is absent in 
MtDTBS, which instead contains a glycine at the equivalent position (G169). As 
nucleotide analogs have proved a successful route to new drugs, there is the potential 
to likewise target the nucleotide pocket of DTBS for new antibiotics. Narrow spectrum 
therapeutics with anti-tuberculi activity would be especially welcome in the fight against 
tuberculosis. However, this requires a greater understanding of the nucleotide binding 
pockets of bacterial DTBS enzymes and the molecular basis of NTP binding.  
Previous attempts to characterize DTBS have been restricted by the lack of facile 
assays. DTBS activity was commonly measured with a spectrophotometric assay by 
monitoring ADP production through the coupling of pyruvate kinase and lactate 
dehydrogenase [19], [16], [19] and [16]. Using two additional enzymes in the reaction is 
less than desirable for high-throughput screening applications. An alternative 
radioactive-labeled carbon fixation assay has been reported for detecting the formation 
of the acid-stable [14C]DTB product using [14C]CO2 [19]. However, complicated 
procedures are required to remove excess [14C]CO2 from the reaction. Recently, a 
continuous fluorescent assay was developed to detect the coupled action of DAPAS 
and DTBS, based on the displacement of a dethiobiotin fluorescent probe bound to 
streptavidin by the DTB product [20]. Although, it is possible to adapt this continuous 
fluorescent assay for detecting the DTBS activity alone, the fluorescent probe is not 
commercially available and must be synthesized via at least four steps [21] and [20].  
In this study, we successfully developed two facile, homogeneous assays to study 
DTBS. These enabling technologies will be beneficial for future drug discovery efforts. 
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Here the assays were employed to characterize DTBS from E. coli and M. tuberculosis. 
The specificity of NTP binding and utilization was investigated. Stark differences were 
observed between the two enzymes with EcDTBS having highest preference for ATP 
whereas MtDTBS showed equal potency for a broad panel of NTPs. A competitive ATP 
binding assay together with surface plasmon resonance analysis (SPR) showed that 
CTP bound to the mycobacterium homologue with greatest affinity. For the first time, the 
structure of MtDTBS was resolved in complex with a nucleotide, namely CTP. X-ray 
crystallography in combination with mutagenesis studies revealed a role for N175 in 
EcDTBS in discriminatory binding of NTPs.  
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2. MATERIALS AND METHODS 
 
2.1 Cloning and plasmid construction. 
The bioD genes encoding DTBS from M. tuberculosis strain H37Rv (Gene ID: 886338) 
and E. coli strain K-12 (Gene ID: 945387), both containing an N-terminal hexa-histidine 
tag, were synthesized as codon optimized genes for expression in E. coli and ligated 
into the pMA vector (GENEART® Gene Synthesis, Life Technologies Australia Pty Ltd.). 
Site directed mutagenesis was performed using the QuickChange® site-directed PCR 
mutagenesis kit (Stratagene) with oligonucleotides synthesized at GeneWorks Pty Ltd 
(Adelaide, Australia). All oligonucleotides used in this study are listed in Table S1. The 
MtDTBS-G169N mutation was constructed using oligonucleotides A1 and A2 whereas 
the two mutants of EcDTBS were constructed with oligonucleotides A3 and A4 for 
EcDTBS-N175G and A5 and A6 for EcDTBS-N175A. For recombinant expression in E. 
coli, the coding regions were subcloned into NcoI and HindIII treated pET16b vector 
(Novagen). All constructs were verified by DNA sequencing using the Gene Sequencing 
Service, SA Pathology (Adelaide, Australia). 
 
2.2 Expression and Protein Purification  
DTBS proteins were recombinantly expressed in E. coli strain BL21(DE3) (Invitrogen). 
Cultured cells were used to inoculate LB medium containing 0.1 mg ml-1 ampicillin and 
grown at 37 ˚C until early log phase when protein expression was induced with 0.1 mM 
IPTG. For EcDTBS and its mutants the cell cultures were induced at 37 ˚C for 3 h, 
whereas the MtDTBS and its mutant were grown for 18 hours at 25 oC. Cells were 
harvested by centrifugation at 4648 x g for 15 min and resuspended in 300 mM KCl, 50 
mM potassium phosphate buffer (pH 8.0), 5 mM imidazole and 1 mM PMSF. Cells were 
lysed using a Microfluidics Cell Disruptor at 18 000 psi and debris removed by 
centrifugation at 48 384 x g for 30 min. His-tagged DTBS proteins were purified by 
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immobilized metal affinity chromatography (IMAC) using the Profinia® IMAC protocol 
following the manufacturer’s instructions (BIO-RAD). After elution in 50 mM potassium 
phosphate buffer (pH 8.0), 300 mM KCl and 250 mM imidazole, the proteins were 
subsequently buffer exchanged into storage buffer (25 mM Tris buffer (pH 7.5), 30 mM 
NaCl, 1 mM EDTA, 1 mM dithiothreitol and 5% (v/v) glycerol) using a 50 ml Bio-ScaleTM 
Mini Bio-Gel® P-6 desalting cartridge (BIO-RAD). For insoluble MtDTBS-G169N the 
inclusion bodies were solubilized in 8 M Urea (pH 8.0), 100 mM Tris, 300 mM NaCl and 
5 mM imidazole. The urea buffer was first deionized using the Mixed Bed Resin (Sigma 
Aldrich®) following the manufacturer’s protocol. The solubilized sample was centrifuged 
at 48 384 x g for 30 min, before fractionation using the Profinia® Denaturing IMAC 
protocol following the manufacturers’ instructions (BIO-RAD). MtDTBS-G169N was 
eluted in 8 M Urea (pH 8.0), 100 mM Tris, 300 mM NaCl and 250 mM imidazole, then 
diluted to 0.2 mg ml-1 for refolding. The protein was dialyzed extensively against storage 
buffer for 48 hours by changing the buffer four times (1:100 (v/v)). DTBS proteins were 
concentrated using Amicon Ultra-15 centrifugal filter devices (Millipore), followed by 
centrifugation at 15 700 x g for 15 min to discard protein aggregates. Protein 
concentrations were determined using a Bradford Protein Assay (BioRad) using bovine 
serum albumin (Sigma Aldrich®) as a standard.  
 
2.3 Protein Methods 
Estimation of the molecular weight of active DTBS material was performed by size 
exclusion chromatography – multi-angle light scattering (SEC-MALS) analysis. The 
instrument consisted of a Superdex 200 10/300 GL column (Amersham Biosciences) 
connected in series with a miniDAWN TREOS light-scattering detector (Wyatt 
Technology) and an OPTILAB rEX interferometric refractometer detector (Wyatt 
Technology). Analytical size-exclusion chromatography was performed at 20° C using a 
mobile phase containing 25 mM Tris pH 7.5, 30 mM NaCl and 1 mM EDTA at a flow 
rate of 0.25 mL/min. Detector outputs were acquired using Astra software (Wyatt 
Technology). 
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The identities of the purified wildtype proteins were confirmed by enzyme assay and 
liquid chromatography-electrospray ionization tandem mass spectrometry, whilst the 
molecular weight of the mutants were confirmed using MALDI mass spectrometry, as 
described in Supporting Methods. All mass spectrometry services were performed at 
the Adelaide Proteomics Center, The University of Adelaide. 
 
2.4 Preparation of Nucleotide triphosphates 
Solutions of NTPs were prepared by dissolving solid compound in sterile water and 
adjusting the pH to 7.0 with sodium hydroxide. The final concentration was determined 
by measuring absorbance at 260 nm, as described in [22]. For assays, the NTPs were 
first mixed with an equimolar concentration of MgCl2 solution to form a MgNTP complex. 
 
2.5 DTBS Enzyme Assay 
The activity of DTBS was determined using fluorescence-polarization (FP) technology to 
quantify the amount of synthesized DTB that could displace fluorescein-biotin (Anaspec 
Inc) from streptavidin. All experiments were performed in black 96 well microtiter plates 
(Costar®) preblocked with 1% casein dissolved in Tris-buffered saline. Assays were 
performed at 37 ˚C in FP buffer (50 mM Tris (pH 7.5), 150 mM NaCl, 5 mM MgCl2, and 
10 mM NaHCO3 (or 50 mM NaHCO3 for MtDTBS-G169N) supplemented with 0.3 mM 
ATP and 0.1 mM DAPA (Toronto Research Chemicals, Inc.). Assays were initiated with 
the addition of DTBS enzyme. The concentration of DTBS in the reaction (at 0.25 – 3.0 
µM) varied depending on its species of origin or mutant employed. The reactions were 
terminated within the initial, linear phase of the reaction at 45 min by the addition of 50 
mM Tris (pH 7.5), 150 mM NaCl, and 250 mM EDTA and then incubated for 15 min at 
37 ˚C. The synthesized DTB product was detected by adding 20 nM streptavidin in 50 
mM Tris (pH 7.5), 150 mM NaCl and incubating for 15 min at 37 °C before the addition 
of 25 nM fluorescein biotin in 50 mM Tris (pH 7.5), 150 mM NaCl. Finally, the reaction 
mixtures were incubated at 37˚C for 15 min before FP was measured with a 
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PerkinElmer 2030 Plate Reader using polarization mode set to 485 nm excitation and 
535 nm emission [23]. FP is defined as the difference of the emission light intensity 
parallel and perpendicular to the excitation light plane; normalized by the total 
fluorescence emission intensity [24] and [25]. The concentration of enzymatically 
generated DTB was calculated from a standard curve generated with each experiment 
(see example in Fig. S6) and using Equation 1; a linear regression binding model where 
S is the slope of the standard curve, Y is the Y intercept and delta mP is the corrected 
FP value (ie mP (streptavidin) – mP (no streptavidin control)).  
Log (DTB (M)) =   - (delta mP + Y)/S           (Eq. 1) 
The data were fit to the Michaelis–Menten equation and the Vmax and Km were then 
calculated using GraphPad Prism 6 (GraphPad Software, Inc.).    
 
2.6 DTBS ATP-binding Assay 
The binding of a fluorescently-labeled ATP tracer, ATP-BODiPY (Life TechnologiesTM), 
to DTBS was performed in binding buffer containing 0.1 mM DTBS, 50 mM Tris (pH 
7.5), 150 mM NaCl, and 5 mM MgCl2. Varying concentrations of MgNTPs were included 
and the reaction pre-equilibrated for 15 min before the addition of 25 nM ATP-BODiPY. 
The reaction was performed at 37 ˚C for 15 min and fluorescence polarization 
measured as described above. The IC50 was measured by plotting the corrected FP 
values (delta mP = mP(DTBS) – mP (no DTBS control)) against log of MgNTP 
concentration and fitting the data to a log (inhibitor) versus response – variable slope 
(four parameters) model in GraphPad Prism 6 (GraphPad Software, Inc.).  
 
2.7 Surface Plasmon Resonance (SPR) 
The kinetics of the interaction between DTBS and NTP were analyzed using a BIAcore 
T100. Details of the protein immobilization and data analysis are described in the 
Supporting Information. Flow cell 1 of the sensor chip was used as reference to correct 
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for bulk refractive index changes. Immobilized bovine serum albumin was also 
employed as control for non-specific binding. Varying concentrations of MgNTP were 
prepared in running buffer (10 mM HEPES (pH 7.4), 150 mM NaCl and 0.005% (v/v) 
surfactant P20) then injected across the sensor surface. The equilibrium binding 
constant (KD) was determined using an affinity-steady state 1:1 model in BIAcore T100 
evaluation software (GE Healthcare). 
 
2.8 X-ray Crystallography 
MtDTBS was concentrated to 10 mg ml-1, to which a final concentration of 1 mM CTP 
was added and incubated for 1 hour at room temperature. The complex was crystallized 
using the hanging drop vapour diffusion method at room temperature. Crystals grew 
from the following range of buffers: 0.8 - 1.2 M ammonium sulphate, 0.1 M Tris pH 7 - 
8.5 with 10 % glycerol. X-ray diffraction data was collected in-house using a Rigaku 
RUH2R rotating copper anode X-ray source equipped with Osmic confocal optics and 
an R-Axis IV detector. Crystals were flash frozen and the diffraction data collected with 
cryo-cooling using an Oxford Cryosystems 700 Series cryostream at 100 K. The 
diffraction data was indexed, merged and integrated using XDS [26], which was also 
used to produce the final MTZ files required for structure refinement. Initial phases of 
the structure were determined with PHASER [27] using the co-ordinates of MtDTBS 
(PDB ID: 3FGN) as a search model. The model of MtDTBS in complex with CTP was 
built with cycles of manual modeling with COOT [28] and refinement with PHENIX [29]. 
The co-ordinates were deposited in the protein database 4WOP. 
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3. RESULTS 
3.1 Purification and biochemical characterization of M. tuberculosis and E. coli DTBS. 
 Genes encoding the two bacterial DTBS enzymes were synthesized and cloned into 
the pET-16b plasmid for recombinant expression in E. coli. A hexa-histidine tag was 
engineered onto the N-terminus of the proteins to facilitate purification using 
immobilized nickel affinity chromatography. EcDTBS expressed as a soluble protein at 
37˚C, whereas the optimal conditions for the M. tuberculosis equivalent were overnight 
at 25˚C. SDS-PAGE analysis of the IMAC purified material revealed high purity (>95%) 
and a single product corresponding to the expected molecular mass of 23.5 kDa for 
MtDTBS or 25.1 kDa for EcDTBS (Fig. S1). Liquid chromatography-electrospray 
ionization tandem mass spectrometry analysis of the tryptic peptides confirmed the 
identity of the purified material, with 47% coverage for MtDTBS and 41% coverage for 
EcDTBS (Table S2). SEC-MALS analysis revealed that >98% of the total proteins 
eluted at a molecular mass consistent with a homodimer (Fig. S2A&B). Interestingly, 
MS/MS sequencing failed to detect endogenous E. coli protein in the MtDTBS 
preparation implying the recombinant mycobacterial protein did not form heterodimers 
with the host protein. 
 
3.2 Enzyme Activity and Assay Development 
To characterize the purified enzymes two alternative assays were developed to 
measure enzyme activity and ATP binding. Both assays incorporated fluorescence 
polarization technology to quantify the difference in anisotropy of a fluorescent tracer 
between its free and protein-bound states [30], [31] and [32]. The enzyme assay 
exploits the observation that DTB, enzymatically produced by DTBS, effectively 
competes with commercially available fluorescein-biotin (Mr 831 Da) to bind streptavidin 
(Mr 67 000 Da). Notably, the tracer did not bind to DTBS (Fig. S3A). Furthermore DTB, 
but not the substrate DAPA, could displace the tracer from streptavidin (Fig. S3B). The 
	   12	  
ATP binding-assay exploits the large mass difference observed between free ATP-
BODiPY (Mr 933 Da) and the tracer in complex with DTBS (Mr 23 500 Da for MtDTBS; 
25 100 Da for EcDTBS). The binding of ATP tracer to DTBS was found to be 
independent of DAPA substrate (Fig. S3C). Both approaches provide convenient, 
homogenous assays using commercially available reagents that yield complementary 
data to quantify the mechanism of ligand binding. The apparent KM for DAPA, NaHCO3 
and ATP were obtained using steady-state kinetic analysis, varying the concentration of 
one substrate whilst maintaining the two others at saturating concentrations. The KM 
values for DAPA and NaHCO3 were calculated to be 15.2 ± 1.7 µM and 0.6 ± 0.1 mM 
for EcDTBS and 30.2 ± 1.1 µM and 3.1 ± 0.4 mM for MtDTBS, respectively (Table 1). In 
this study, the KM for ATP for MtDTBS (30.2 ± 1.7 µM) was 3-fold higher than that of 
EcDTBS (10.5 ± 0.8 µM), but these values were in excellent agreement with published 
literature for the two enzymes [15, 33].  
The activity of the DTBS enzymes was initially measured in the presence of each of a 
panel of NTPs at 0.3 mM. Unexpectedly, MtDTBS was able to utilize any of ATP, CTP, 
GTP, ITP, TTP and UTP (Fig. 1). These observations were in stark contrast to the E. 
coli homologue where the enzyme had greatest preference for ATP, a result consistent 
with published literature [33]. Further kinetic analysis showed that MtDTBS utilized all 
nucleotides with similar KM’s and kcat’s while EcDTBS could use CTP and GTP albeit 
with more than 100-fold and 150-fold higher KMs than ATP, respectively (Fig. 2 & Table 
1). This nucleotide specificity was confirmed in the ATP-binding assay where all 
nucleotides could compete effectively against the ATP-BODiPY tracer for binding 
MtDTBS (Fig. 3). Here, CTP was observed to have the greatest binding affinity with a 
6-fold lower IC50 than ATP in MtDTBS (Table 2). Consistent with the enzyme assay, 
ATP was the preferred NTP in EcDTBS with >10-fold lower IC50 values than CTP and 
GTP. SPR analysis was also employed to measure the bimolecular interactions 
between DTBS and nucleotide triphosphates. Again, this confirmed that both ATP and 
CTP bound to MtDTBS (Fig. 4A) with CTP demonstrating the highest affinity (KD CTP = 
17.2 ± 1.7 µM; ATP = 335.1 ± 96.0 µM) (Fig. S4A&B). In contrast, EcDTBS was highly 
selective for ATP (KD of 347.9 ± 75.1 µM) over CTP where no response was observed 
(Fig. 4B and Fig. S4C). Injection of NTPs over either an empty flow cell or immobilized 
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bovine serum albumin (BSA), performed concurrently with the immobilized DTBS 
experiment, resulted in negligible response (Fig 4D, and data not shown). This 
confirmed the specificity of NTP binding to the DTBS enzymes.  
 
3.3 X-ray Crystallography – To date there have been no X-ray structures available of 
MtDTBS in complex with a nucleotide triphosphate. To better understand the molecular 
basis of ligand binding, MtDTBS was crystallized in complex with CTP (Fig. 5). The 
structure was determined to 2.3 Å; data collection, refinement, and geometric statistics 
are provided in Table S3. Repeated attempts to crystallize the enzyme with ATP were 
unsuccessful. As expected, our structures were consistent with the α/β-fold observed in 
the published structures for E. coli, H. pylori and F. tularensis DTBS [18]. 
Superimposition of chain D of our structure against chain D of a previously reported 
apo-structure for M. tuberculosis (PDB # 3FGN [15]) had the lowest RMSD of 0.387 Å 
(for 224 Cα atoms), and the same fold of a seven-stranded parallel β-sheet surrounded 
by seven helices. Superimposition of the two dimeric forms of the crystallized structures 
(chain A and B) were also in excellent agreement with an RMSD of 0.40 Å (for 225 Cα 
atoms). These results indicated that there are no large conformational changes that 
accompany CTP binding. Whilst the enzyme crystallized as a dimer of dimers, the NTP-
binding site is distant from the dimer interface and all the residues contacting the NTP 
are present within a single subunit. MtDTBS possesses the classical P-loop motif 
(Walker A motif) with Gly12, Val13, Gly14, Lys15 and Thr16 all forming hydrogen 
bonding interactions with the triphosphate moiety on CTP. A series of hydrophobic 
interactions involving C2 and the 2’ hydroxyl on the ribose with the side chain of Val 17 
and the beta carbon of Ala 201 stabilize the sugar in its binding pocket (Fig. S5). CTP 
adopted a bent conformation with rotation around the C-N bond between ribosyl and 
cytosinyl groups to allow the pyrimidine ring to bind in its appropriate pocket. Two 
hydrophobic interactions are observed between the pyrimidine ring and the protein, 
namely C5 with Ser170 and C6 with Val17 in the P-loop. The interaction is further 
stabilized through three hydrogen-bonding interactions with the pyrimidine ring. What is 
noteworthy is that all three of these bonds are with the protein backbone and not with 
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amino acid side chains; O2 bonds with the nitrogen of Ala201 whilst N4 bonds with the 
backbone oxygen atoms of Gly169 and Pro197.  
The lack of side chain interactions contacting the nucleotide base observed in MtDTBS 
is in contrast to the E. coli homologue, in which the carboxamide side chain on Asn175 
forms hydrogen-bonding interactions with N6 and N7 on the purine ring of ATP (Fig. 6) 
[14]. This side chain interaction is also present in H. pylori, which selectively binds ATP 
[18]. It has previously been proposed that side chain interactions involving asparagine 
play a key role in nucleotide specificity [34] and [18], but this has not been tested 
experimentally. To uncover the function of this asparagine in NTP binding, an 
asparagine residue was engineered into the M. tuberculosis enzyme at the structurally 
equivalent position to Asn175 in EcDTBS, thereby generating MtDTBS-G169N. 
Likewise, two muteins of the E. coli homologue were generated by substituting Asn175 
with either glycine or alanine (producing EcDTBS-N175G and EcDTBS-N175A).  
 
3.4 Purification and biochemical characterization of mutants 
EcDTBS-N175G and EcDTBS-N175A were expressed as soluble proteins in E. coli 
allowing their purification by IMAC. In contrast, MtDTBS-G169N formed inclusion bodies 
and, therefore, required refolding. MtDTBS-G169N was purified using IMAC under 
denaturing conditions and then refolded by a four step-wise dialysis procedure to 
restore enzyme activity. SEC-MALS analysis revealed that only 25% of the refolded 
MtDTBS-G169N material eluted as a homodimer, with the majority of the material 
forming inactive protein aggregates (Fig. S2C). Following size exclusion 
chromatography the specific enzyme activity of active, dimeric MtDTBS-G169N (56.2 
µM min-1 mg-1) was comparable to that measured for the wildtype MtDTBS (74.0 µM 
min-1 mg-1). To confirm the identity of the muteins, MALDI mass spectrometry was 
performed. The measured molecular mass corresponding to methionine removed DTBS 
[M+H]+ was in agreement with the predicted molecular mass (Table S4). 
The mutant enzymes all showed KM values for DAPA comparable to their wildtype 
counterparts (Table 1), suggesting that the introduced mutations had not compromised 
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enzymatic activity nor the DAPA binding site. Whilst the two substitutions in the E. coli 
enzyme had no significant effect on the KM for NaHCO3, the G169N mutation in 
MtDTBS elevated the Km for the carbonate 3-fold (WT vs G169N, p<0.05) (Table 1). 
The molecular explanation for this is unclear. 
Substitution of N175 in EcDTBS with alanine or glycine had no effect on the KM for ATP 
(EcDTBS-N175G vs WT, p=0.11; EcDTBS-N175A vs WT p=0.19). Whilst the Km for 
CTP was not significantly different for EcDTBS-N175G, the introduction of alanine 
significantly lowered the KM for CTP by 2.7-fold (EcDTBS-N175A vs WT, p<0.05) 
implying that hydrophobic interactions help stabilize the interaction between protein and 
NTP. This was supported by SPR analysis that also demonstrated that the binding of 
CTP was improved for EcDTBS-N175A (Fig. 4C). These kinetic data are in contrast to 
the MtDTBS-G169N mutant. Whilst the affinity for ATP was again unchanged (MtDTBS-
G169N vs WT, p = 0.09), the asparagine substitution significantly elevated the KM for 
both CTP and GTP by 1.8-fold and 3.8-fold respectively. Unfortunately, attempts to 
immobilize the MtDTBS-G169N for SPR analysis were unsuccessful. Together these 
data support a role for N175 in excluding other NTPs from the nucleoside-binding 
pocket, thus allowing selective binding of ATP. Without the ‘gate keeper’ asparagine, 
MtDTBS can accommodate a broad range of NTPs. 
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4. DISCUSSION 
It has previously been proposed that DTBS is more similar to GTP-binding proteins than 
ATP-dependent enzymes based on its fold [35] and the presence of the [NQ]-[KR]-x-
[DE] GTP specificity motif in the E. coli, H. pylori and F. tularensis enzymes (containing 
NDVTP, NLKGN, and NCNDS motifs respectively) [18]. The first asparagine in this motif 
(numbering N175 in EcDTBS) was suggested to be an evolutionary relic from a protein 
able to bind both adenosine and guanine nucleotides and provides nucleotide specificity 
[34] and [18]. Curiously, in the current study, DTBS from M. tuberculosis was shown to 
be capable of binding ATP and GTP, as well as other nucleotides, with similar affinities 
despite the enzyme being devoid of the equivalent asparagine. Here, for the first time, 
we present the structure of MtDTBS in complex with a nucleotide (CTP). The structural 
data revealed that the hydrogen bonding interactions with the nucleoside occurred 
exclusively through the peptide backbone of the enzyme, and not via side chains. 
Indeed, with the absence of Asn175 (equivalent position of G169 in MtDTBS) or the 
reduction of hydrophobic interactions at C5 of the pyrimidine ring with S170 (MtDTBS-
S170D, data not shown), the MtDTBS retained the ability to bind all nucleotides.  
To further understand the molecular basis of NTP binding to DTBS, we superimposed 
the structure of EcDTBS in complex with ATP (PDB # 1A82 [14]) and HpDTBS in 
complex with ATP or GDP (PDB # 3QXC, 3QXX [18]) onto the CTP bound MtDTBS 
structure. In the published X-ray structures, ATP and GTP both adopt an extended 
conformation that would cause a significant steric clash with MtDTBS in the nucleotide-
binding pocket. Compared to the more open pockets observed in EcDTBS and 
HpDTBS, MtDTBS has a more constrained pocket due to additional strands at the C-
terminus of the enzyme. Presumed flexibility at the loops formed by G169 – W171 and 
A195 – A201 would allow accommodation of other NTPs in the nucleotide pocket.  
The biological significance of the selective binding reported here may be a function of 
the concentrations of NTPs found in different bacteria. For E. coli and Salmonella 
enterica, it has been reported that ATP is the most abundant NTP, with concentrations 
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being at least 3 mM [36] and [37]. This is >300 times above the KM for ATP measured in 
this study for EcDTBS suggesting that ATP is constantly at saturating concentrations in 
vivo. The levels of various NTPs can decrease as E. coli transitions from growth to 
stationary phase. Interestingly, of all the NTPs, CTP had the most constant 
concentration throughout the whole growth curve, with only minor fluctuations in its 
levels. In Mycobacteria there is an abundant supply of all NTPs during all stages of cell 
growth [38]. Here nucleoside diphosphate kinase plays an important role in NTP 
synthesis by utilizing both purine and pyrimidine NDP as substrates to produce NTPs. 
Nucleoside diphosphate kinase can also form complexes with several proteins, and this 
has been shown to alter the specificity of substrate binding thereby directing the 
synthesis of specific NTPs as required during active cell growth. For example, M. 
tuberculosis cell wall protein A, a homologue of protein P60 in Mycobacterium 
smegmatis, can induce the specificity of nucleoside diphosphate kinase towards CTP 
synthesis [39]. Therefore, we propose that the broad specificity observed in this study 
for the MtDTBS provides the tuberculi with the potential to scavenge alternative NTPs 
depending upon availability. This previously unrecognized mechanism ensures that the 
activity of this important enzyme, and the biotin biosynthetic pathway, is maintained.
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FIGURE LEGENDS 
Fig. 1. NTP specificity. The specificity of MtDTBS (black bars) and EcDTBS (white bars) 
for different nucleotides was measured in the presence of 0.1 mM DAPA, 10 mM 
NaHCO3, and 0.3 mM NTP. The specificity is presented as the percentage of enzyme 
activity normalized to 100% of enzyme activity using ATP. 
Fig. 2. Enzyme analysis. The Km of nucleotide substrates for both MtDTBS (A – C) and 
EcDTBS (D – F) were determined by varying the concentrations of ATP, CTP and GTP 
in the reaction containing 0.1 mM DAPA and 10 mM NaHCO3. 
Fig. 3. NTP Binding to DTBS. Competitive binding assays using a fluorescent ATP 
tracer and various NTPs to (A) MtDTBS and (B) EcDTBS. NTPs employed were ATP 
(green circle), CTP (blue square), GTP (black triangle), ITP (black star), TTP (black 
diamond), and UTP (black square). 
Fig. 4. Surface plasmon resonance analysis. The sensorgrams represent the binding of 
ATP (green lines) and CTP (blue lines) to (A) MtDTBS, (B) EcDTBS and (C), EcDTBS-
N175A. (D) BSA was included as a negative control to demonstrate specific binding of 
nucleotide to DTBS. HEPES running buffer alone (red line) was also included. The 
experiment was performed at a single concentration of nucleotide (0.3 mM). 
Fig. 5. Crystal structure of MtDTBS in complex with CTP. (A) Cartoon diagram of the 
MtDTBS dimer in complex with CTP. Subunit A is colored in gray and subunit B is 
colored in green. CTP is shown in pink stick representation. (B) The hydrogen bond 
network formed between amino acid residues of MtDTBS and CTP is shown. Hydrogen 
bonds are indicated as dashed lines.  
Fig. 6. Superimposition of MtDTBS and EcDTBS. The glycine at position Gly169 (grey), 
in MtDTBS, is located at the equivalent position of Asn175 in EcDTBS, as shown in 
blue. While two hydrogen bonds (shown as dashed lines) formed between the side 
chain of Asn175 in EcDTBS and ATP (PDB # 1A82 [14], shown in cyan), these 
interactions are missing in MtDTBS. 
TABLE 1. Kinetic analysis of substrates.
Enzymes Substrates Km (μM) kcat (s
-1) (x 10-3)
MtDTBS DAPA 30.2 ± 1.1 13.3 ± 0.7
NaHCO3   3074.3 ± 352.4 9.9 ± 0.6
ATP 30.2 ± 1.7 11.7 ± 0.2
CTP 25.2 ± 1.7 15.2 ± 0.3
GTP 26.3 ± 0.5 11.1 ± 0.1
ITP 17.7 ± 1.7 10.2 ± 1.2
TTP 23.2 ± 1.4 11.8 ± 0.8
UTP 26.1 ± 0.5 11.4 ± 0.8
EcDTBS DAPA 15.2 ± 1.7 49.0 ± 1.0
NaHCO3 599.8 ± 72.3  38.4 ± 3.4
ATP 10.5 ± 0.8 38.6 ± 2.5













MtDTBS-G169N DAPA 15.1 ± 5.7   0.9 ± 0.3
NaHCO3 10385.3 ± 2248.0   1.7 ± 0.4
ATP 21.5 ± 3.2   1.3 ± 0.2
CTP 45.1 ± 4.9   1.0 ± 0.1
GTP 100.7 ± 12.8   1.2 ± 0.1
EcDTBS-
N175Gb
DAPA 18.0 ± 2.3 23.2 ± 3.2
NaHCO3 383.6 ± 64.0 15.4 ± 1.0
ATP 17.3 ± 2.6 23.6 ± 4.6
CTP 869.0 ± 55.9 19.6 ± 2.5
GTP 1386.8 ± 236.5 16.3 ± 1.6
EcDTBS-
N175Ab
DAPA 18.8 ± 0.2   0.9 ± 0.3
NaHCO3   433.0 ± 128.4 16.2 ± 1.9
ATP 12.3 ± 0.9 18.1 ± 3.3
CTP 390.9 ± 97.3 19.1 ± 1.6
GTP 1096.9 ± 121.3 18.3 ± 2.3
N/D, Not determined. Km and Kcat values were calculated from three independent experiments and 
reported as mean ± SEM. 
TABLE 2. Nucleotide binding to MtDTBS and EcDTBS using DTBS ATP-
binding assay
Enzymes Substrates IC50 (μM)
MtDTBS ATP 348.8 ± 15.3
CTP 54.4 ± 4.3
GTP 596.6 ± 51.3
ITP 520.3 ± 60.0
TTP 622.3 ± 19.5
UTP 636.4 ± 18.0
EcDTBS ATP 436.9 ± 39.1
CTP 5752.6 ± 852.5 
GTP > 2000
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SUPPLEMENTARY FIGURES 
 
Fig S1. SDS-PAGE analysis of recombinant MtDTBS and EcDTBS.  
SDS-PAGE analysis of IMAC purified MtDTBS (23.5 kDa, lane 1) and EcDTBS (25.1 
kDa, lane 2). The migration of molecular mass standards is shown on the left. The 
samples were estimated to be > 95% pure. Both proteins migrated through the gel with 












IC50 = 348.80(n=3)  
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Fig S2. SEC-MALS analysis of MtDTBS, EcDTBS, and MtDTBS-G169N.  
Proteins were fractionated on a Superdex 200 10/300 GL gel filtration column 
connected in series with a miniDAWN TREOS light-scattering detector (Wyatt 
Technology) and an OPTILAB rEX interferometric refractometer detector (Wyatt 
Technology). Analytical size-exclusion chromatography was performed at 20° C using a 
mobile phase containing 25 mM Tris pH 7.5, 30 mM NaCl and 1 mM EDTA at a flow 
rate of 0.25 mL/min. BSA was employed as the reference sample during calibration. 
Chromatograms of the refractive index are shown for (A) MtDTBS and (B) EcDTBS. 
Both samples eluted with molecular masses of 47 and 46 kDa respectively, consistent 
with the proteins being dimers. (C) In contrast, only 25% of refolded MtDTBS-G169N 
eluted in the dimer peak, with most of the protein observed in a high molecular mass 
aggregate. The percentage of the eluted protein was calculated from the proportion of 
the area under the curves on the chromatograms using ImageJ 1.46r (National Institute 
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Fig S3. Controls of FP detection in DTBS enzyme assay. 
 A, Fluorescein-biotin does not bind to DTBS. B, DAPA did not displace the 
streptavidin:fluorescein-biotin complex in the assay containing 25 nM fluorescein-biotin 
and 20 nM streptavidin. Likewise, C, the DTBS:ATP-BODiPY complex was not 
disrupted by increasing concentrations of DAPA in the binding reaction implying that 
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Fig S4. Surface plasmon resonance analysis.  
Isotherms showing binding of (A) ATP and (B) CTP to MtDTBS and (C) ATP to 
EcDTBS. Data were analyzed using an affinity-steady state 1:1 model. The time-
dependent binding curves of ligands correlated to dose-response are also shown 
(insert). The equilibrium-binding constant (KD) of ATP and CTP to MtDTBS was 
calculated to be 335.1 ± 96.0 µM (n = 3) and 17.2 ± 1.7 µM (n = 3). The KD for ATP 
binding to EcDTBS was calculated to be 347.9 ± 75.1 µM (n = 3). No response was 
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Fig S5. Mode of CTP binding within the MtDTBS active site.  
Residues interacting with the substrate CTP in the DTBS active site are shown in this 
figure, prepared using Ligplot. The protein residues are colored brown, and the ligand 
CTP is colored purple. Hydrogen bonds are shown in green dotted lines. Hydrophobic 
interactions are shown in brick red sunbursts. Atoms are colored by type (Carbon, 
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Fig S6. Representative calibration curve of DTB concentration.  
The concentration of DTB was determined from a standard curve generated by 
incubating 25 nM fluorescein-biotin and 20 nM streptavidin with varying amounts of 
DTB. Each DTB concentration was assayed in triplicate, and the data points 



























Log (DTB (M)) =  - (ΔmP + Y)/S 




















TABLE S2. Mascot LC-ESI-MS/MS search results  





MtDTBS His6-MtDTBS 158 / 593 47 
 
EcDTBS ATP-dependent EcDTBS 
(trIB1X7A8IB1X7A8_ECODH) 
221 / 586 41 

















TABLE S3. Data Collection, Refinement, and Geometry Statistics of MtDTBS in 
complex with CTP 
 CTP-MtDTBS 
Data collection 
Wavelength (Å)  
Space group 
Cell dimensions   
    a, b, c (Å) 








1.54 (Cu anode) 
P 212121 
 
54.7, 104.6, 152.7 
90, 90, 90 








No. of reflections 
Rwork / Rfree 
No. of atoms 
    Protein 
    Ligand/ion 
    Water 





    Bond lengths (Å) 
    Bond angles (°) 
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TABLE S4. Molecular mass of the wildtype and mutant DTBS measured by MALDI-MS. 
DTBS enzymes 
Methionine removed mass (Da) 
















a The measured mass considered the initiator methionine had been post-translationally removed.  
  
	   S11 
SUPPLEMENTARY EXPERIMENTAL PROCEDURES 
 
Surface Plasmon Resonance 
The kinetics of the interaction between DTBS and NTPs were analysed using a BIAcore 
T100. DTBS enzymes were immobilized onto the surface of a CM5 sensor chip using 
amide-coupling chemistry. After activating the surface with EDC and NHS, DTBS 
solution at concentration of 0.2 mg ml-1 in 0.01 M sodium acetate buffer pH 5.2 was 
applied at a constant flow rate of 5 µl min-1 for 420 s. Approximately 10,000 response 
units (RU) of ligands were immobilized. Typically, no immobilized ligand (empty flow 
cell) and immobilized bovine serum albumin (BSA) were performed alongside 
immobilized DTBS in order to correct for bulk refractive index changes with buffer and 
distinguish non-specific binding events, respectively. Water-soluble NTPs were diluted 
in running buffer (10 mM HEPES (pH 7.4), 150 mM NaCl and 0.005% (v/v) surfactant 
P20). Binding experiments were performed by injecting the analyte solutions across the 
sensor surface of all flow cells at a flow rate of 30 µl min-1 with a contact time of 60 sec 
followed by a dissociation time of 60 sec. The time-dependent binding curves from all 
four flow cells were monitored simultaneously.  
As the analyte bound to the immobilized DTBS, the refractive index at the surface alters 
in proportion to the change in mass, resulting in change of RU value. The binding 
capacity of the surface depends on the level and activity of immobilized ligand. The 
maximum binding capacity (RMAX) of the immobilized ligand was calculated using 
Equation 1 where MW is the molecular weight of the ligand and analyte, RL is the 
amount of immobilized ligand in RU, and SM is the stoichiometry as defined by the 
number of binding sites on the ligand (Guiducci, 2010). The percent activity of the 
immobilized ligand that reflects the quality of binding was determined using Equation 2 
(Guiducci, 2010). 
Equation 1:             RMAX  =   (MWanalyte / MWligand) x RL x SM 
Equation 2:           % ligand activity = (Rmaxexperiment / Rmaxtheory) x 100% 
The binding affinity (KD) was determined by transforming the time-dependent binding 




LC-ESI-MS/MS was acquired using an 1100 series HPLC system (Agilent 
Technologies) coupled via an Advance CaptiveSpray source (Michrom Bioresources, 
Inc.) to an amaZon ETD mass spectrometer (Bruker Daltonics). Samples were initially 
run on a 4-12% gradient SDS-PAGE gel and stained with coomassie blue dye. Bands 
were excised from the gel manually and processed with a trypsin digestion protocol 
(Shevchenko et al., 2006). Collision-induced dissociation (CID) spectra were acquired to 
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select the two most abundant ionisable species in the 300-2000 m/z range at any point 
in the LC separation. The acquired spectra were subjected to peak detection and de-
convolution using DataAnalysis version 4.0 SP4 Build 281 (Bruker Daltonics). 
Processed MS/MS spectra were exported to Mascot generic format (mgf) and submitted 
to Mascot version 2.3.02 for identification by comparison to the amino acid sequences 
of His6-MtDTBS, His6-EcDTBS, MtDTBS, EcDTBS and common contaminants (i.e. 
human keratins and porcine trypsin) from Uniprot.  
MALDI-MS was acquired on an ultrafleXtreme MALDI-TOF/TOF mass spectrometer 
(Bruker Daltonics) operating in a linear positive mode under the control of flexControl 
software version 3.4 (Bruker Daltonik GmbH). Samples were desalted by spotting onto 
nitrocellulose filters 0.025 µm MF-membrane filters VSWP0500 (Millipore) and dialyzing 
in 800 ml of 0.1% TFA for 2 hr. One microliter of each sample was mixed with 1 µl of 
sinapinic acid saturated TA30 (30% ACN in 0.1% FA). Next, the sample matrix was 
prepared by spotting the 1 µl sample mix onto the dried matrix spots which were 
previously spotted with 2 µl of sinapinic acid saturated ethanol onto a ground steel 
target plate (Bruker Daltonics) and then air dried. Sample m/z range was set to 5000 – 
55000 Da. 50000 shots were collected for the external calibration and sample 
measurement. External calibration was performed using a mix of protein calibration 
standard I and II ( Bruker Daltonics). Laser intensity and detector gain was manually 
adjusted for optimal resolution. The MS spectra obtained were analysed using 
flexAnalysis software version 3.3 (Bruker Daltonics) employing smoothing, background 
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